THURSDAY, Sept. 7, 2023 (HealthDay News) -- For patients with inflammatory bowel disease (IBD), statin use is associated with a reduced risk for colorectal cancer (CRC) incidence and mortality, according to a study published online Aug. 24 in eClinicalMedicine. Jiangwei Sun, Ph.D., from the Karolinska Institutet in Sweden, and colleagues examined the association between statin